ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,917.11
0.00%
US Tech 100
20,110.40
-0.08%
다우존스 지수
43,408.47
0.32%
Bitcoin
98,026.97
3.89%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 유럽
  5. EU

  6. Ab Science (AB) 시세

Ab Science

Ab Science (AB)

AllianceBernstein Holding LP
0.802
-0.02
( -2.43% )
업데이트: 20:04:48
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
0.802
매수가
0.802
매도가
0.818
거래량
21,012
0.80 일간 변동폭 0.823
0.80 52주 범위 4.465
market_cap
41.761M
전일 종가
0.822
개장가
0.822
최근 거래 시간
115
@
0.802
마지막 거래 시간
20:06:14
재정 규모
-
VWAP
-
평균 볼륨(3m)
35,025
발행 주식
52,071,069
배당수익률
-
주가수익률
-3.48
주당순이익(EPS)
-0.23
매출
970k
순이익
-11.99M

Ab Science 정보

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.ab-science.com
본부
Paris, Paris, Fra
설립됨
-
Ab Science is listed in the Pharmaceutical Preparations sector of the 유로넥스트 (Euronext) with ticker AB. The last closing price for Ab Science was 0.82 €. Over the last year, Ab Science shares have traded in a share price range of 0.80 € to 4.465 €.

Ab Science currently has 52,071,069 shares in issue. The market capitalisation of Ab Science is 42.80 € million. Ab Science has a price to earnings ratio (PE ratio) of -3.48.

AB 최신 뉴스

추가 뉴스

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN...

29 10월 2024
UK Regulatory

AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose

AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose COMMUNIQUE DE PRESSE AB SCIENCE REÇOIT UN AVIS...

29 10월 2024
UK Regulatory

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease

PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL DISEASE THIS DECISION FURTHER STRENGTHENS MASITINIB’S...

29 10월 2024
GlobeNewswire Inc.

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL...

18 10월 2024
UK Regulatory

AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA

AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA COMMUNIQUE DE PRESSE AB SCIENCE FAIT LE POINT SUR LA DEMANDE...

18 10월 2024
UK Regulatory

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS

PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL MARKETING AUTHORISATION OF MASITINIB IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Paris, 17 October, 2024...

18 10월 2024
GlobeNewswire Inc.

AB Science : Résultats financiers semestriels au 30 juin 2024 et point sur les activités d’AB Science

AB Science : Résultats financiers semestriels au 30 juin 2024 et point sur les activités d’AB Science          COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTE SES RÉSULTATS FINANCIERS AU PREMIER SEMESTRE...

10 10월 2024
UK Regulatory

AB Science: Revenues for the first half of 2024 and update on AB Science’s activities

AB Science: Revenues for the first half of 2024 and update on AB Science’s activities          PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2024 AND THE KEY EVENTS...

10 10월 2024
UK Regulatory

AB Science: Revenues for the first half of 2024 and update on AB Science’s activities

         PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2024 AND THE KEY EVENTS OF THE PERIOD Clinical development Masitinib platform: Ongoing re-examination by...

10 10월 2024
GlobeNewswire Inc.

AB Science annonce avoir réalisé le règlement livraison de sa dernière augmentation de capital de 5,0 millions d’euros

AB Science annonce avoir réalisé le règlement livraison de sa dernière augmentation de capital de 5,0 millions d’euros COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE AVOIR REALISE LE REGLEMENT LIVRAISON...

09 10월 2024
UK Regulatory
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.109-11.96487376510.9110.9380.8543020.86686287DE
4-0.184-18.66125760650.9861.050.8400380.93896874DE
12-0.276-25.60296846011.0781.0780.8350250.97805967DE
26-1.323-62.25882352942.1252.1550.8702271.25149884DE
52-2.088-72.24913494812.894.4650.8997482.23317557DE
156-11.448-93.453061224512.2513.340.8953874.70619732DE
260-4.228-84.0556660045.0321.750.81449368.45867132DE

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
BIDSGascogne DS
0.0054 €
(200.00%)
63.85k
ALCYBCybergun
0.0002 €
(100.00%)
2.52M
ALMASMastrad
0.0134 €
(55.81%)
4.96M
ALNEVNeovacs
0.0003 €
(50.00%)
42.5M
ATODSAtos SE
0.006 €
(46.34%)
17.47M
EBUSEbusco Holding NV
0.9149 €
(-25.38%)
1.91M
FINMFinanciere Marjos
0.076 €
(-20.83%)
110
MLCMGCMG Clean Tech
1.00 €
(-17.36%)
1.76k
VACBSPierre & Vacances
0.048 €
(-14.29%)
427
ALMUNMunic S.A.
0.576 €
(-12.99%)
6.64k
ALNEVNeovacs
0.0003 €
(50.00%)
42.5M
ATODSAtos SE
0.006 €
(46.34%)
17.47M
ALTDTonner Drones
0.01 €
(8.70%)
11.79M
ALVERVergnet
0.0046 €
(-4.17%)
9.95M
BCPBanco Comercial Portugues SA
0.4395 €
(-0.07%)
9.31M

토론

전체 피드 보기
mrcskwd mrcskwd 4 분 전
The Quicken Help Center (+1-888-848-2409), and submitting a request via form provided. Quicken Support phone number 1-877-845-5947 no wait.
Quicken customer service can be reached by calling: (+1-888-848-2409). Available seven days a week, 5 am - 5 pm PST for Chat Support.
Quicken's S
shtsqsh shtsqsh 4 분 전
Now that's funny! Fleetwood Mac only became much better after Green left to join Syd Barrett on a bench outside of Nurse Ratched's office.
StayHumble StayHumble 4 분 전
🇺🇸Hearing a MOASS takes $DJT to MARS🇺🇸wow🇺🇸🇺🇸
DJT
PennyStaIker PennyStaIker 4 분 전
Kraken Robotics Reports Q3 2024 Financial Results
KRKNF
Investor2014 Investor2014 4 분 전
As there is a lot talk about and use of LMMs like ChatGPT to 'help' understand e.g. the chance of approval for Anavex in AD. This talk gives an easy to follow and in depth understanding of the capabilities and limitations of this type of AI.

[yt]JTU8Ha4Jyfc[/yt]
AVXL
Investor082 Investor082 5 분 전
Wait for the UK approval spike and don't get too greedy, waiting for the partnership news! ;) It wont have any upfront cash attached and will lead to another disappointment as a shareholder. It’s best to invest whatever cash is left in a well funded, better managed, and one that has a history of del
NWBO
mrcskwd mrcskwd 5 분 전
The Quicken Help Center (+1-888-848-2409), and submitting a request via form provided. Quicken Support phone number 1-877-845-5947 no wait.
Quicken customer service can be reached by calling: (+1-888-848-2409). Available seven days a week, 5 am - 5 pm PST for Chat Support.
Quicken's S
AugustaFriends AugustaFriends 5 분 전
Good morning Orions!!
mrcskwd mrcskwd 7 분 전
The Quicken Help Center (+1-888-848-2409), and submitting a request via form provided. Quicken Support phone number 1-877-845-5947 no wait.
Quicken customer service can be reached by calling: (+1-888-848-2409). Available seven days a week, 5 am - 5 pm PST for Chat Support.
Quicken's S
StayHumble StayHumble 7 분 전
Wow✅Silver is the New Gold✅✅Spooky✅ ✅ ✅
HYMC
mrcskwd mrcskwd 8 분 전
The Quicken Help Center (+1-888-848-2409), and submitting a request via form provided. Quicken Support phone number 1-877-845-5947 no wait.
Quicken customer service can be reached by calling: (+1-888-848-2409). Available seven days a week, 5 am - 5 pm PST for Chat Support.
Quicken's S
healthcare healthcare 8 분 전
https://www.en-us-pawbiotix.colibrip.com/ Pawbiotix is an innovative nutritional supplement crafted to enhance your dog's overall health by optimizing gut balance. It targets five essential gut bacteria, key for digestion, immunity, and energy. As a top-rated Pawbiotix dog health Supplement 2024,
NWBO
Investor2014 Investor2014 8 분 전
Many here do indeed need to think much more as an investors in a speculative stock.

Biotech is not for everyone.
AVXL
KVM KVM 8 분 전
Every time I review there many useless PRs and ECs alls I read about is over 90% retention rates, multiple new customers every q, demand exploding, pipeline biggest ever and growing, leader in enterprise Ai, leading the Ai revolution, thousands of customers and partners, can't be more excited, refle
VERI
SkyTrader7 SkyTrader7 9 분 전
Yup interesting volume 
NWPN
Freddie bagholder Freddie bagholder 9 분 전
Will new treasury secretary talk about gses in first interview like Mnuchin did? If yes I expect at least a double from here.
FNMA
StarryBuccaneer80 StarryBuccaneer80 10 분 전
Contact DeFi wallet Support Number +1(53O)-447-2879 by Phone, simply go with This is the official support number where you can get assistance for any issues or questions related to DeFi wallet Account. This dedicated line connects you directly with DeFi wallet experts who can assist with all your pr
StarryBuccaneer80 StarryBuccaneer80 10 분 전
Contact DeFi wallet Support Number +1(53O)-447-2879 by Phone, simply go with This is the official support number where you can get assistance for any issues or questions related to DeFi wallet Account. This dedicated line connects you directly with DeFi wallet experts who can assist with all your pr
mrcskwd mrcskwd 11 분 전
The Quicken Help Center (+1-888-848-2409), and submitting a request via form provided. Quicken Support phone number 1-877-845-5947 no wait.
Quicken customer service can be reached by calling: (+1-888-848-2409). Available seven days a week, 5 am - 5 pm PST for Chat Support.
Quicken's S
Investor2014 Investor2014 12 분 전
How is it going with that other biotech you have been pumping and the Investment Group?
AVXL
Nrdc92 Nrdc92 12 분 전
It's willful denial. It brings me no pleasure to write this, but stack Lightmatter side-by-side with LWLG, and one will see the difference between a well run company (Lm) and one that's not (LWLG). Lm has multiple strategic partners, third party capital raises, a compelling technology, and is very w
LWLG
edbi46 edbi46 12 분 전
Lets see how high our beloved BIEL gets TRUMPed/JFK JUNIORed/DR. OZed up by Jan. 1, before NOPAIN Act is activated ( and, specifically, after!!! ) !!! HEHEHE

No WORD SALADS, no SUBSTANTIAL/NONE SUBSTANTIAL ACCUSATIONS, ( for like 20 years and counting?? ),
did/will do any desir
MCF WBA
SPANISH_gladiator SPANISH_gladiator 13 분 전
Poor Termite7 has hallucinations
RMTD
Jp_SHMP Jp_SHMP 13 분 전
if you sell you never gonna be able to get thoses 4M back at low price

after watching the lates video online and understanding the link with the
gouvernement and the entity merging for the nasdaq uplist, I am even more
confident

Absolute new era of consom
IGPK

최근 히스토리

EU
AB
Ab Science
LSE
AAL
Anglo American
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유